TUESDAY, Sept. 13 (HealthDay News) -- Searching for cancer in
lots of lymph nodes after colon cancer surgery does not seem to
increase patients' chances of survival, a new study finds.
Researchers from the U.S. National Cancer Institute analyzed
data on more than 86,000 cancer patients from the Surveillance,
Epidemiology and End Results (SEER) cancer registry.
The investigators found that over the past 20 years, there's
been a trend toward pathologists evaluating more and more lymph
nodes in the hunt for cancer cells that have spread beyond the
colon, according to the study in the Sept. 14 issue of the
Journal of the American Medical Association.
Though there can be variations in treatment, colon cancer
patients whose tumors have metastasized, or spread to the lymph
nodes, typically receive chemotherapy, while those with localized
tumors are often treated with surgery alone, explained study author
Helen Parsons, a public health advisor at the U.S. National Cancer
Presumably, evaluating more lymph nodes would increase the
chances of finding cancer cells that have spread and help to get
patients the right level of treatment, Parsons said.
During 1988-1990, about 35 percent of the patients studied had
12 lymph nodes or more evaluated. That rose to 47 percent in
2000-2002 and to nearly 74 percent in 2006-2008, according to the
And yet, despite evaluating so many more lymph nodes,
pathologists didn't identify many more metastatic cancers.
In 1988-1990, about 40 percent of colon cancers were found to
have spread to the lymph nodes, rising only slightly to 42 percent
"We found that while the number of lymph nodes patients had evaluated increased dramatically over the past 20 years, it hasn't led to significant increases in the overall proportion of lymph node-positive colon cancers identified," Parsons said.
Still, there was an association between the number of lymph
nodes evaluated and survival. Patients who had more lymph nodes
evaluated had a greater chance of surviving for five years than
those with none or just a few nodes evaluated.
For example, patients with no nodes evaluated were 1.2 times
more likely to die than those who had one to eight nodes evaluated
regardless of whether the nodes were found to be cancerous or not.
Patients who had between 12 and 15 nodes evaluated were 17 percent
less likely to die than those who only had between one and eight
evaluated; patients who had more than 40 nodes evaluated had a 36
percent decreased risk of death.
Put another way, about 55.4 percent of patients with no nodes
evaluated died within five years; that dropped to 46.6 percent of
those who had 12 to 15 evaluated and 33.3 percent of those who had
more than 40 nodes evaluated.
But since there wasn't a strong link between evaluating more
nodes and finding more cancers, researchers concluded that other
qualities about the doctors or the hospitals may explain the
differences in survival rates, rather than the node evaluation
"Patients who had a large number of lymph nodes evaluated were only slightly more likely to be lymph node-positive than those who had only a few lymph nodes evaluated, and yet the group that got more lymph nodes evaluated had significantly lower mortality," Parsons said. "That suggests that something else . . . is the primary mechanism by which we are seeing the relationship."
Lymph node evaluation is one measure that's being used to assess
hospital quality, but the study calls into question whether it's a
useful measure, Parsons said. The National Quality Forum and
several surgical consensus panels all recommend testing 12 or more
lymph nodes, Parsons said.
Prior research has shown that if cancer is going to be found in
lymph nodes, the chances are it will be found in the first five or
so lymph nodes, and then the odds of turning up cancer drop quickly
from there, Parsons said.
"We're not saying we shouldn't evaluate lymph nodes. It's still important. But using this as a measure for reimbursement, or a marker for quality may have a limited impact on improving survival," she added.
In an accompanying editorial, Dr. Sandra Wong, an assistant
professor of surgery at University of Michigan, said the research
is more evidence that evaluating lots and lots of lymph nodes after
surgery for colon cancer doesn't seem to help cancer patients
Wong was the author of a 2007 study that found hospitals that
did a lot of node evaluation didn't have better colon cancer
survival rates than hospitals that did less.
"The theory that evaluating lots of nodes can help you find more positive nodes isn't holding up," Wong said.
But this study found an association with greater survival, which
suggests a "missing link" to explain it.
That missing link may lie in the details of the surgery or what
treatment the patient received after surgery, information the
researchers weren't able to consider, she said. It's a question
worth answering, Wong added.
"There is so much focus on finding these lymph nodes," she said. "Those are resources we could be using to improve cancer care, such as providing more colonoscopies or making sure people who have a positive node get chemotherapy."
U.S. National Cancer Institute has more on staging
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.